一名印度患者接种新冠疫苗后发生脑膜脑炎的病例报告。
Case report on meningoenceplapathy in an Indian patient post CoViD vaccination.
作者信息
Choudhry Raj Kamal, Singh Amrendra Kumar, Sourav Kumar, Pervez Anjum, Kumar Abilesh, Kumar Subham
机构信息
Jawaharlal Nehru Medical College and Hospital, Bhagalpur, Bihar, India.
出版信息
Bioinformation. 2023 Jan 31;19(1):117-119. doi: 10.6026/97320630019117. eCollection 2023.
Abstract
The SARS-COV-2 infection-related severe illness is prevented by vaccinations. Therefore, it is relevant to report a case of post vaccine meningoencephalitis in a 30 year old male Indian patient, who presented with weakness in all the extremities, episodes of loose stool, fever, vomiting, tachypnea and loss of consciousness immediately following the 2nd dose of the COVID vaccination (COVAXIN).
摘要
接种疫苗可预防与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染相关的重症疾病。因此，报告一例30岁印度男性患者接种疫苗后发生脑膜脑炎的病例具有重要意义。该患者在接种第二剂新冠疫苗（科维沙欣）后立即出现四肢无力、腹泻、发热、呕吐、呼吸急促和意识丧失。
相似文献
1
Case report on meningoenceplapathy in an Indian patient post CoViD vaccination.一名印度患者接种新冠疫苗后发生脑膜脑炎的病例报告。
Bioinformation. 2023 Jan 31;19(1):117-119. doi: 10.6026/97320630019117. eCollection 2023.
2
Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India.印度 COVID-19 疫苗（Covaxin）对突破感染 SARS-CoV-2 的有效性。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2034456. doi: 10.1080/21645515.2022.2034456. Epub 2022 Mar 23.
3
Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152).一种鼻内 COVID-19 候选疫苗（BBV154）的初步临床安全性和免疫原性评估，以及 COVAXIN（BBV152）异源初免-加强策略的体液免疫原性评估。
Front Immunol. 2022 Dec 8;13:1063679. doi: 10.3389/fimmu.2022.1063679. eCollection 2022.
4
Post-Vaccination/Post-COVID Immune-Mediated Demyelination of the Brain and Spinal Cord: A Novel Neuroimaging Finding.接种疫苗后/感染新冠病毒后大脑和脊髓的免疫介导性脱髓鞘：一项新的神经影像学发现
Neurol India. 2023 Jan-Feb;71(1):86-91. doi: 10.4103/0028-3886.370449.
5
Facial Palsy Induced by Covaxin in Adolescent Female - A Rare Case Report.科瓦克辛导致青少年女性面瘫——一例罕见病例报告。
Curr Drug Saf. 2023;18(4):603-605. doi: 10.2174/1574886318666221228120829.
6
Generalised Tonic-Clonic Seizure in Adolescents Following COVID-19 Vaccination: A Case Report on a Mere Co-incidence.COVID-19疫苗接种后青少年的全身性强直阵挛发作：一例纯属巧合的病例报告
Cureus. 2023 Jun 26;15(6):e40992. doi: 10.7759/cureus.40992. eCollection 2023 Jun.
7
Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran.伊朗比尔詹德市医护人员中新冠病毒疫苗（卫星五号、阿斯利康新冠疫苗和科瓦克辛）副作用的发生率
Int Immunopharmacol. 2021 Dec;101(Pt B):108351. doi: 10.1016/j.intimp.2021.108351. Epub 2021 Nov 10.
8
Aseptic meningoencephalitis after COVID-19 vaccination: A case report.新型冠状病毒肺炎疫苗接种后无菌性脑膜脑炎：一例报告
Ann Med Surg (Lond). 2021 Nov;71:103028. doi: 10.1016/j.amsu.2021.103028. Epub 2021 Nov 5.
9
Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study.印度 2021 年 BBV152/Covaxin 和 AZD1222/Covishield 疫苗对严重 COVID-19 和 B.1.617.2/Delta 变异株的有效性：一项多中心医院病例对照研究。
Int J Infect Dis. 2022 Sep;122:693-702. doi: 10.1016/j.ijid.2022.07.033. Epub 2022 Jul 16.
10
Assessment of safety and adverse drug reactions of COVID vaccination in the South Indian population: An observational prospective cross-sectional study.印度南部人群新冠疫苗接种的安全性及药物不良反应评估：一项观察性前瞻性横断面研究。
Ann Med Surg (Lond). 2022 Nov 18;84:104948. doi: 10.1016/j.amsu.2022.104948. eCollection 2022 Dec.
引用本文的文献
1
Post-COVID-19 Vaccination Meningitis and Meningoencephalitis: A Systematic Review of Case Series and Case Reports.新冠病毒感染后疫苗接种相关脑膜炎和脑膜脑炎：病例系列及病例报告的系统评价
Am J Trop Med Hyg. 2024 Oct 22;112(1):30-36. doi: 10.4269/ajtmh.24-0451. Print 2025 Jan 8.
本文引用的文献
1
Aseptic meningoencephalitis after COVID-19 vaccination: A case report.新型冠状病毒肺炎疫苗接种后无菌性脑膜脑炎：一例报告
Ann Med Surg (Lond). 2021 Nov;71:103028. doi: 10.1016/j.amsu.2021.103028. Epub 2021 Nov 5.
2
Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine.接种BNT162b2 mRNA新冠疫苗后发生的无菌性脑膜炎。
Neurol Sci. 2021 Nov;42(11):4433-4435. doi: 10.1007/s10072-021-05543-1. Epub 2021 Aug 11.
3
Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.疫苗接种后 COVID-19 疫苗诱导的免疫性血栓性血小板减少症和脑静脉窦血栓形成：系统评价。
J Neurol Sci. 2021 Sep 15;428:117607. doi: 10.1016/j.jns.2021.117607. Epub 2021 Aug 3.
4
SARS-CoV-2 vaccinations are unsafe for those experiencing post-vaccination Guillain-Barre syndrome.对于那些接种疫苗后出现吉兰-巴雷综合征的人来说，接种新型冠状病毒2型疫苗是不安全的。
Ann Med Surg (Lond). 2021 Aug;68:102584. doi: 10.1016/j.amsu.2021.102584. Epub 2021 Jul 19.
5
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study.墨西哥 704003 名第一剂 BNT162b2 mRNA COVID-19 疫苗接种者的神经不良反应：一项全国描述性研究。
Clin Immunol. 2021 Aug;229:108786. doi: 10.1016/j.clim.2021.108786. Epub 2021 Jun 18.
6
Association of consciousness impairment and mortality in people with COVID-19.新型冠状病毒肺炎患者意识障碍与死亡率的关联
Acta Neurol Scand. 2021 Sep;144(3):251-259. doi: 10.1111/ane.13471. Epub 2021 May 24.
7
SARS-CoV-2 vaccines are not free of neurological side effects.新型冠状病毒2型疫苗并非没有神经方面的副作用。
Acta Neurol Scand. 2021 Jul;144(1):109-110. doi: 10.1111/ane.13451. Epub 2021 May 17.
8
SARS-CoV-2 vaccine-related neurological complications need large collaborative studies, not single case reports or small descriptive series.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗相关的神经系统并发症需要大型合作研究，而非单病例报告或小型描述性系列研究。
Eur J Neurol. 2021 Oct;28(10):3223. doi: 10.1111/ene.14905. Epub 2021 May 22.
9
Safety of COVID-19 vaccines administered in the EU: Should we be concerned?在欧盟接种的新冠疫苗的安全性：我们应该担心吗？
Toxicol Rep. 2021;8:871-879. doi: 10.1016/j.toxrep.2021.04.003. Epub 2021 Apr 20.
10
Bell's Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell's palsy.一名有复发性贝尔麻痹病史的患者在接种第二剂辉瑞新冠疫苗后出现贝尔麻痹。
Brain Behav Immun Health. 2021 May;13:100217. doi: 10.1016/j.bbih.2021.100217. Epub 2021 Feb 10.
Zotero 插件